Find Research outputs

Search results

• A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome

  Daver, N., Vega-Ruiz, A., Kantarjian, H. M., Estrov, Z., Ferrajoli, A., Kornblau, S., Verstovsek, S., Garcia-Manero, G. & Cortes, J. E., Sep 2013, In: European Journal of Cancer Care. 22, 5, p. 605-611 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  11 Scopus citations

• A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL

  Jain, N., Balakrishnan, K., Ferrajoli, A., O'Brien, S. M., Burger, J. A., Kadia, T. M., Cortes, J. E., Ayres, M. L., Tambaro, F. P., Keating, M. J., Gandhi, V. & Wierda, W. G., 2017, In: Oncotarget. 8, 13, p. 22104-22112 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  5 Scopus citations

• A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: A phase II study of the Gynecologic Oncology

  Miller, D. S., Blessing, J. A., Drake, R. D., Higgins, R., McMeekin, D. S., Puneky, L. V. & Krasner, C. N., Dec 2009, In: Gynecologic Oncology. 115, 3, p. 443-446 4 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study

  Leslie, K. K., Sill, M. W., Fischer, E., Darcy, K. M., Mannel, R. S., Tewari, K. S., Hanjani, P., Wilken, J. A., Baron, A. T., Godwin, A. K., Schilder, R. J., Singh, M. & Maihle, N. J., Jun 2013, In: Gynecologic Oncology. 129, 3, p. 486-494 9 p.

  Research output: Contribution to journal › Article › peer-review
  56 Scopus citations

• A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study

  Chan, J. K., Deng, W., Higgins, R. V., Tewari, K. S., Bonebrake, A. J., Hicks, M., Gaillard, S., Ramirez, P. T., Chafe, W., Monk, B. J. & Aghajanian, C., Sep 2017, In: Gynecologic Oncology. 146, 3, p. 554-559 6 p.

  Research output: Contribution to journal › Article › peer-review
  14 Scopus citations

• A phase II clinical trial of a natural formulation containing tea catechins for xerostomia

  De Rossi, S. S., Thoppay, J., Dickinson, D. P., Looney, S., Stuart, M., Ogbureke, K. U. E. & Hsu, S., Oct 1 2014, In: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 118, 4, p. 447-454.e3

  Research output: Contribution to journal › Article › peer-review
  11 Scopus citations

• A phase IIa randomized controlled pilot study evaluating the safety and clinical outcomes following the use of rhGDF-5/β-TCP in regenerative periodontal therapy

  Windisch, P., Stavropoulos, A., Molnár, B., Szendröi-Kiss, D., Szilágyi, E., Rosta, P., Horváth, A., Capsius, B., Wikesjö, U. M. E. & Sculean, A., Aug 2012, In: Clinical oral investigations. 16, 4, p. 1181-1189 9 p.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase IIa randomized controlled clinical and histological pilot study evaluating rhGDF-5/β-TCP for periodontal regeneration

  Stavropoulos, A., Windisch, P., Gera, I., Capsius, B., Sculean, A. & Wikesjö, U. M. E., Nov 1 2011, In: Journal of Clinical Periodontology. 38, 11, p. 1044-1054 11 p.

  Research output: Contribution to journal › Article › peer-review
  47 Scopus citations

• A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction

  Hellstrom, W. J. G., Freier, M. T., Serefoglu, E. C., Lewis, R. W., Didonato, K. & Peterson, C. A., Jan 2013, In: BJU International. 111, 1, p. 137-147 11 p.

  Research output: Contribution to journal › Article › peer-review
  27 Scopus citations

• A phase i clinical trial of guadecitabine and carboplatin in platinum-resistant, recurrent ovarian cancer: Clinical, pharmacokinetic, and pharmacodynamic analyses

  Matei, D., Ghamande, S., Roman, L., Secord, A. A., Nemunaitis, J., Markham, M. J., Nephew, K. P., Jueliger, S., Oganesian, A., Naim, S., Su, X. Y., Keer, H., Azab, M. & Fleming, G. F., May 15 2018, In: Clinical Cancer Research. 24, 10, p. 2285-2293 9 p.

  Research output: Contribution to journal › Article › peer-review
  40 Scopus citations

• A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2

  Holmlund, J. T., Kopp, W. C., Wiltrout, R. H., Longo, D. L., Urba, W. J., Janik, J. E., Sznol, M., Conlon, K. C., Fenton, R. G., Hornung, R., Madara, K., Shields, M. A., Smith, J. W., Sharfman, W., Steis, R. G., Ewel, C., Malspeis, L. & Creekmore, S. P., Jan 18 1995, In: Journal of the National Cancer Institute. 87, 2, p. 134-136 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  4 Scopus citations

• A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies

  Wise-Draper, T. M., Moorthy, G., Salkeni, M. A., Karim, N. A., Thomas, H. E., Mercer, C. A., Beg, M. S., O’Gara, S., Olowokure, O., Fathallah, H., Kozma, S. C., Thomas, G., Rixe, O., Desai, P. & Morris, J. C., Jun 1 2017, In: Targeted Oncology. 12, 3, p. 323-332 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  69 Scopus citations

• A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia

  Stock, W., Undevia, S. D., Bivins, C., Ravandi, F., Odenike, O., Faderl, S., Rich, E., Borthakur, G., Godley, L., Verstovsek, S., Artz, A., Wierda, W., Larson, R. A., Zhang, Y., Cortes, J., Ratain, M. J. & Giles, F. J., Aug 2008, In: Investigational New Drugs. 26, 4, p. 331-338 8 p.

  Research output: Contribution to journal › Article › peer-review
  4 Scopus citations

• A Phase I and Pharmacokinetic Study of VNP40101M, a Novel Sulfonylhydrazine Alkylating Agent, in Patients with Refractory Leukemia

  Giles, F. J., Thomas, D., Garcia-Manero, G., Faderl, S., Cortes, J., Verstovsek, S., Ferrajoli, A., Jeha, S., Beran, M., Koller, C., Andreeff, M., Cahill, A., Clairmont, C., Sznol, M. & Kantarjian, H., May 1 2004, In: Clinical Cancer Research. 10, 9, p. 2908-2917 10 p.

  Research output: Contribution to journal › Article › peer-review
  40 Scopus citations

• A phase i and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis

  Foran, J., Ravandi, F., Wierda, W., Garcia-Manero, G., Verstovsek, S., Kadia, T., Burger, J., Yule, M., Langford, G., Lyons, J., Ayrton, J., Lock, V., Borthakur, G., Cortes, J. & Kantarjian, H., Jun 2014, In: Clinical Lymphoma, Myeloma and Leukemia. 14, 3, p. 223-230 8 p.

  Research output: Contribution to journal › Article › peer-review
  33 Scopus citations

• A phase I/II study of the mTOR inhibitor everolimus in combination with hyperCVAD chemotherapy in patients with relapsed/refractory acute lymphoblastic leukemia

  Daver, N., Boumber, Y., Kantarjian, H., Ravandi, F., Cortes, J., Rytting, M. E., Kawedia, J. D., Basnett, J., Culotta, K. S., Zeng, Z., Lu, H., Richie, M. A., Garris, R., Xiao, L., Liu, W., Baggerly, K. A., Jabbour, E., O'Brien, S., Burger, J., Bendall, L. J., & 2 othersThomas, D. & Konopleva, M., Jun 15 2015, In: Clinical Cancer Research. 21, 12, p. 2704-2714 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  43 Scopus citations

• A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemia

  Pemmaraju, N., Kantarjian, H., Kadia, T., Cortes, J., Borthakur, G., Newberry, K., Garcia-Manero, G., Ravandi, F., Jabbour, E., Dellasala, S., Pierce, S. & Verstovsek, S., Mar 1 2015, In: Clinical Lymphoma, Myeloma and Leukemia. 15, 3, p. 171-176 6 p.

  Research output: Contribution to journal › Article › peer-review
  61 Scopus citations

• A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome

  Swaminathan, M., Kantarjian, H. M., Levis, M., Guerra, V., Borthakur, G., Alvarado, Y., DiNardo, C. D., Kadia, T., Garcia-Manero, G., Ohanian, M., Daver, N., Konopleva, M., Pemmaraju, N., Ferrajol, A., Andreeff, M., Jain, N., Estrov, Z., Jabbour, E. J., Wierda, W. G., Pierce, S., & 4 othersPinsoy, M. R., Xiao, L., Ravandi, F. & Cortes, J. E., Aug 2021, In: Haematologica. 106, 8, p. 2121-2130 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  26 Scopus citations

• A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia

  Short, N. J., Kantarjian, H., Ravandi, F., Huang, X., Xiao, L., Garcia-Manero, G., Plunkett, W., Gandhi, V., Sasaki, K., Pemmaraju, N., Daver, N. G., Borthakur, G., Jain, N., Konopleva, M., Estrov, Z., Kadia, T. M., Wierda, W. G., DiNardo, C. D., Brandt, M., O’Brien, S. M., & 2 othersCortes, J. E. & Jabbour, E., Jul 19 2018, In: Leukemia and Lymphoma. 59, 4, p. 813-820 8 p.

  Research output: Contribution to journal › Article › peer-review
  16 Scopus citations

• A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis

  Verstovsek, S., Hoffman, R., Mascarenhas, J., Soria, J. C., Bahleda, R., McCoon, P., Tang, W., Cortes, J., Kantarjian, H. & Ribrag, V., Feb 1 2015, In: Leukemia Research. 39, 2, p. 157-163 7 p.

  Research output: Contribution to journal › Article › peer-review
  27 Scopus citations

• A phase 3 trial of L-Glutamine in sickle cell disease

  Kumar Guddati, A. & Vamsi Kota, K., Nov 8 2018, In: New England Journal of Medicine. 379, 19, p. 1879 1 p.

  Research output: Contribution to journal › Letter › peer-review
  18 Scopus citations

• A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

  Réa, D., Mauro, M. J., Boquimpani, C., Minami, Y., Lomaia, E., Voloshin, S., Turkina, A., Kim, D. W., Apperley, J. F., Abdo, A., Fogliatto, L. M., Kim, D. D. H., le Coutre, P., Saussele, S., Annunziata, M., Hughes, T. P., Chaudhri, N., Sasaki, K., Chee, L., García-Gutiérrez, V., & 6 othersCortes, J. E., Aimone, P., Allepuz, A., Quenet, S., Bédoucha, V. & Hochhaus, A., Nov 25 2021, In: Blood. 138, 21, p. 2031-2041 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  87 Scopus citations

• A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

  Cortes, J. E., Kim, D. W., Pinilla-Ibarz, J., Le Coutre, P., Paquette, R., Chuah, C., Nicolini, F. E., Apperley, J. F., Khoury, H. J., Talpaz, M., DiPersio, J., DeAngelo, D. J., Abruzzese, E., Rea, D., Baccarani, M., Müller, M. C., Gambacorti-Passerini, C., Wong, S., Lustgarten, S., Rivera, V. M., & 10 othersClackson, T., Turner, C. D., Haluska, F. G., Guilhot, F., Deininger, M. W., Hochhaus, A., Hughes, T., Goldman, J. M., Shah, N. P. & Kantarjian, H., 2013, In: New England Journal of Medicine. 369, 19, p. 1783-1796 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  827 Scopus citations

• A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

  Masarova, L., Verstovsek, S., Hidalgo-Lopez, J. E., Pemmaraju, N., Bose, P., Estrov, Z., Jabbour, E. J., Ravandi-Kashani, F., Takahashi, K., Cortes, J. E., Ning, J., Ohanian, M., Alvarado, Y., Zhou, L., Pierce, S., Gergis, R., Patel, K. P., Luthra, R., Kadia, T. M., DiNardo, C. D., & 6 othersBorthakur, G., Bhalla, K., Garcia-Manero, G., Bueso-Ramos, C. E., Kantarjian, H. M. & Daver, N., Oct 18 2018, In: Blood. 132, 16, p. 1664-1674 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  49 Scopus citations

• A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer

  Stein, S. M., Tiersten, A., Hochster, H. S., Blank, S. V., Pothuri, B., Curtin, J., Shapira, I., Levinson, B., Ivy, P., Joseph, B., Guddati, A. K. & Muggia, F., 2013, In: International Journal of Gynecological Cancer. 23, 9, p. 1577-1582 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  8 Scopus citations

• A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia

  Seymour, J. F., Kim, D. W., Rubin, E., Haregewoin, A., Clark, J., Watson, P., Hughes, T., Dufva, I., Jimenez, J. L., Mahon, F. X., Rousselot, P., Cortes, J., Martinelli, G., Papayannidis, C., Nagler, A. & Giles, F. J., Aug 2014, In: Blood Cancer Journal. 4, 8, e238.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  55 Scopus citations

• A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction

  Tita, C., Gilbert, E. M., Van Bakel, A. B., Grzybowski, J., Haas, G. J., Jarrah, M., Dunlap, S. H., Gottlieb, S. S., Klapholz, M., Patel, P. C., Pfister, R., Seidler, T., Shah, K. B., Zieliński, T., Venuti, R. P., Cowart, D., Foo, S. Y., Vishnevsky, A. & Mitrovic, V., Oct 2017, In: European Journal of Heart Failure. 19, 10, p. 1321-1332 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  41 Scopus citations

• A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

  Ghamande, S. A., Silverman, M. H., Huh, W., Behbakht, K., Ball, G., Cuasay, L., Würtz, S. O., Brunner, N. & Gold, M. A., Oct 2008, In: Gynecologic Oncology. 111, 1, p. 89-94 6 p.

  Research output: Contribution to journal › Article › peer-review
  39 Scopus citations

• A Phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

  Ghamande, S. A., Silverman, M. & Gold, M., Jul 2009, In: Gynecologic Oncology. 114, 1, p. 137 1 p.

  Research output: Contribution to journal › Letter › peer-review
  1 Scopus citations

• A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

  Monk, B. J., Brady, M. F., Aghajanian, C., Lankes, H. A., Rizack, T., Leach, J., Fowler, J. M., Higgins, R., Hanjani, P., Morgan, M., Edwards, R., Bradley, W., Kolevska, T., Foukas, P., Swisher, E. M., Anderson, K. S., Gottardo, R., Bryan, J. K., Newkirk, M., Manjarrez, K. L., & 3 othersMannel, R. S., Hershberg, R. M. & Coukos, G., May 1 2017, In: Annals of oncology : official journal of the European Society for Medical Oncology. 28, 5, p. 996-1004 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  47 Scopus citations

• A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III

  Hillier, S. L., Ferrieri, P., Edwards, M. S., Ewell, M., Ferris, D., Fine, P., Carey, V., Meyn, L., Hoagland, D., Kasper, D. L., Paoletti, L. C., Hill, H. & Baker, C. J., Jun 2019, In: Clinical Infectious Diseases. 68, 12, p. 2079-2086 8 p., ciy838.

  Research output: Contribution to journal › Article › peer-review
  23 Scopus citations

• A phase 2, open-label study of the safety and efficacy of intravenous anidulafungin as a treatment for azole-refractory mucosal candidiasis

  Vazquez, J. A., Schranz, J. A., Clark, K., Goldstein, B. P., Reboli, A. & Fichtenbaum, C., Jul 1 2008, In: Journal of Acquired Immune Deficiency Syndromes. 48, 3, p. 304-309 6 p.

  Research output: Contribution to journal › Article › peer-review
  37 Scopus citations

• A phase 2, double-blinded, placebo-controlled trial of toll-like receptor 7/8/9 antagonist, IMO-8400, in dermatomyositis

  Kim, Y. J., Schiopu, E., Dankó, K., Mozaffar, T., Chunduru, S., Lees, K., Goyal, N. A., Sarazin, J., Fiorentino, D. F. & Sarin, K. Y., Apr 2021, In: Journal of the American Academy of Dermatology. 84, 4, p. 1160-1162 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  3 Scopus citations

• A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML

  Fathi, A. T., Erba, H. P., Lancet, J. E., Stein, E. M., Ravandi, F., Faderl, S., Walter, R. B., Advani, A. S., DeAngelo, D. J., Kovacsovics, T. J., Jillella, A., Bixby, D., Levy, M. Y., O’Meara, M. M., Ho, P. A., Voellinger, J. & Stein, A. S., Sep 13 2018, In: Blood. 132, 11, p. 1125-1133 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  44 Scopus citations

• A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

  Stein, E. M., Walter, R. B., Erba, H. P., Fathi, A. T., Advani, A. S., Lancet, J. E., Ravandi, F., Kovacsovics, T., DeAngelo, D. J., Bixby, D., Faderl, S., Jillella, A. P., Ho, P. A., O'Meara, M. M., Zhao, B., Biddle-Snead, C. & Stein, A. S., Jan 25 2018, In: Blood. 131, 4, p. 387-396 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  107 Scopus citations

• A phase 1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase®) in adult subjects with well-controlled asthma

  Colombo, R. E., Fiorentino, C., Dodd, L. E., Hunsberger, S., Haney, C., Barrett, K., Nabha, L., Davey, R. T. & Olivier, K. N., Feb 1 2016, In: BMC Infectious Diseases. 16, 1, 54.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  16 Scopus citations

• A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors

  Ghamande, S., Lin, C. C., Cho, D. C., Shapiro, G. I., Kwak, E. L., Silverman, M. H., Tseng, Y., Kuo, M. W., Mach, W. B., Hsu, S. C., Coleman, T., Yang, J. C. H., Cheng, A. L., Ghalib, M. H., Chuadhary, I. & Goel, S., Jun 2014, In: Investigational New Drugs. 32, 3, p. 445-451 7 p.

  Research output: Contribution to journal › Article › peer-review
  20 Scopus citations

• A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ≤30% blasts

  Garcia-Manero, G., Sekeres, M. A., Egyed, M., Breccia, M., Graux, C., Cavenagh, J. D., Salman, H., Illes, A., Fenaux, P., Deangelo, D. J., Stauder, R., Yee, K., Zhu, N., Lee, J. H., Valcarcel, D., Macwhannell, A., Borbenyi, Z., Gazi, L., Acharyya, S., Ide, S., & 2 othersMarker, M. & Ottmann, O. G., 2017, In: Leukemia. 31, 12, p. 2799-2806 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  47 Scopus citations

• A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome

  Jabbour, E., Kantarjian, H., Ravandi, F., Garcia-Manero, G., Estrov, Z., Verstovsek, S., O'Brien, S., Faderl, S., Thomas, D. A., Wright, J. J. & Cortes, J., Mar 15 2011, In: Cancer. 117, 6, p. 1236-1244 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  32 Scopus citations

• A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease

  Kutlar, A., Ataga, K., Reid, M., Vichinsky, E. P., Neumayr, L., Blair-Britt, L., Labotka, R., Glass, J., Keefer, J. R., Wargin, W. A., Berenson, R. & Perrine, S. P., Nov 2012, In: American Journal of Hematology. 87, 11, p. 1017-1021 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  25 Scopus citations

• A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

  Bose, P., Verstovsek, S., Cortes, J. E., Tse, S., Gasior, Y., Jain, N., Jabbour, E. J., Estrov, Z., Alvarado, Y., DiNardo, C. D., Pemmaraju, N., Kornblau, S. M., Kadia, T. M., Daver, N. G., Naqvi, K., Short, N. J., Masarova, L., Villareal, J., Pierce, S. A., Nogueras-Gonzalez, G., & 4 othersHuang, X., Garcia-Manero, G., Kantarjian, H. M. & Ravandi, F., Sep 1 2020, In: Leukemia. 34, 9, p. 2489-2492 4 p.

  Research output: Contribution to journal › Letter › peer-review
  26 Scopus citations

• A pharmacotherapy review of the novel, oral antithrombotics

  Walters, K. J., Meador, A., Galdo, J. A. & Ciarrocca, K., Mar 1 2017, In: Special Care in Dentistry. 37, 2, p. 62-70 9 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• A pharmacokinetic-pharmacodynamic model for a muscle relaxant: Atracurium

  Nigrovic, V., Gaspari, J. & Banoub, M., Jan 1 1996, In: European Journal of Clinical Pharmacology. 49, 4, p. 325-332 8 p.

  Research output: Contribution to journal › Article › peer-review
  2 Scopus citations

• A pharmacogenetic versus a clinical algorithm for warfarin dosing

  Kimmel, S. E., French, B., Kasner, S. E., Johnson, J. A., Anderson, J. L., Gage, B. F., Rosenberg, Y. D., Eby, C. S., Madigan, R. A., McBane, R. B., Abdel-Rahman, S. Z., Stevens, S. M., Yale, S., Mohler, E. R., Fang, M. C., Shah, V., Horenstein, R. B., Limdi, N. A., Muldowney, J. A. S., Gujral, J. S., & 11 othersDelafontaine, P., Desnick, R. J., Ortel, T. L., Billett, H. H., Pendleton, R. C., Geller, N. L., Halperin, J. L., Goldhaber, S. Z., Caldwell, M. D., Califf, R. M. & Ellenberg, J. H., 2013, In: New England Journal of Medicine. 369, 24, p. 2283-2293 11 p.

  Research output: Contribution to journal › Article › peer-review
  616 Scopus citations

• A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response

  Pratz, K. W., Cortes, J., Roboz, G. J., Rao, N., Arowojolu, O., Stine, A., Shiotsu, Y., Shudo, A., Akinaga, S., Small, D., Karp, J. E. & Levis, M., 2009, In: Unknown Journal. 113, 17, p. 3938-3946 9 p.

  Research output: Contribution to journal › Article › peer-review
  51 Scopus citations

• Aphaenogaster ichnusa santschi, 1925, bona species, and redescription of aphaenogaster subterranea (latreille, 1798) (hymenoptera, formicidae)

  Galkowski, C., Aubert, C. & Blatrix, R., 2019, In: Sociobiology. 66, 3, p. 420-425 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  10 Scopus citations

• A perspective on promoting diversity in the biomedical research workforce: The national heart, lung, and blood institute's pri de program

  Boyington, J. E. A., Maihle, N. J., Rice, T. K., Gonzalez, J. E., Hess, C. A., Makala, L. H., Jeffe, D. B., Ogedegbe, G., Rao, D. C., Dávila-Román, V. G., Pace, B. S., Jean-Louis, G. & Boutjdir, M., Jun 1 2016, In: Ethnicity and Disease. 26, 3, p. 379-386 8 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access
  13 Scopus citations

• A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy

  Wallbillich, J. J., Forde, B., Havrilesky, LJ. & Cohn, DE., Jul 2016, In: Gynecologic Oncology. 142, 1, p. 144-149 6 p., 27106017.

  Research output: Contribution to journal › Article › peer-review

  11 Scopus citations

• A personalized medicine approach to ovulation induction/ovarian stimulation: development of a predictive model and online calculator from level-I evidence

  for the Eunice Kennedy Schriver National Institute of Child Health and Human Development Reproductive Medicine Network, Feb 2022, In: Fertility and sterility. 117, 2, p. 408-418 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  3 Scopus citations

• A periurethral mass in a 25-year-old woman

  Robinson, B. L., Jan 1 2014, Acute Care and Emergency Gynecology: A Case-Based Approach. Cambridge University Press, p. 252-254 3 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter